<DOC>
	<DOCNO>NCT00572338</DOCNO>
	<brief_summary>The purpose study learn myeloma cell grow become cancer , distinguish normal cell eliminate cell selectively .</brief_summary>
	<brief_title>Therapeutic Research Multiple Myeloma</brief_title>
	<detailed_description>Participating study require blood bone marrow sample obtain part diagnostic work-up follow-up multiple myeloma . Bone marrow/peripheral blood/tissue sample collect research purpose , well test genetic trait Castleman 's disease consent study . In addition , data collect include demographic information gather medical record , include gender , date birth , ethnicity , date diagnosis , laboratory pathology result , treatment protocol , date relapse , subsequent treatment protocol , current treatment medication .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Any subject evaluate MIRT protocol Subjects evaluate MIRT protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>